Titre : Émulsion lipidique intraveineuse

Émulsion lipidique intraveineuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Infant, Extremely Premature
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Émulsion lipidique intraveineuse : Questions médicales les plus fréquentes", "headline": "Émulsion lipidique intraveineuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Émulsion lipidique intraveineuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-30", "dateModified": "2024-12-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Émulsion lipidique intraveineuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Solutions d'alimentation parentérale", "url": "https://recherchemedicale.com/mesh/D057947", "about": { "@type": "MedicalCondition", "name": "Solutions d'alimentation parentérale", "code": { "@type": "MedicalCode", "code": "D057947", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.752.733" } } }, "about": { "@type": "MedicalCondition", "name": "Émulsion lipidique intraveineuse", "alternateName": "Fat Emulsions, Intravenous", "code": { "@type": "MedicalCode", "code": "D005217", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kara L Calkins", "url": "https://recherchemedicale.com/author/Kara%20L%20Calkins", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Division of Neonatology & Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA." } }, { "@type": "Person", "name": "Mark Puder", "url": "https://recherchemedicale.com/author/Mark%20Puder", "affiliation": { "@type": "Organization", "name": "Harvard Medical School, Boston, MA, United States; Department of Surgery and the Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States." } }, { "@type": "Person", "name": "Camila de Souza Paglarini", "url": "https://recherchemedicale.com/author/Camila%20de%20Souza%20Paglarini", "affiliation": { "@type": "Organization", "name": "Department of Food Technology, School of Food Engineering, University of Campinas, Unicamp, 13083-862 Campinas, SP, Brazil." } }, { "@type": "Person", "name": "Gustavo R Alvira-Arill", "url": "https://recherchemedicale.com/author/Gustavo%20R%20Alvira-Arill", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA." } }, { "@type": "Person", "name": "Brian M Peters", "url": "https://recherchemedicale.com/author/Brian%20M%20Peters", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Dutch professionals' discussion preferences with the parents of extremely premature infants varied, but the trend was towards shared decision-making.", "datePublished": "2023-03-06", "url": "https://recherchemedicale.com/article/36811350", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apa.16721" } }, { "@type": "ScholarlyArticle", "name": "Renal Function After Transcatheter Piccolo Patent Ductus Arteriosus Closure With Contrast Angiography in Extremely Premature Infants.", "datePublished": "2022-08-13", "url": "https://recherchemedicale.com/article/35970628", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amjcard.2022.07.013" } }, { "@type": "ScholarlyArticle", "name": "Perinatal care for the extremely preterm infant.", "datePublished": "2022-04-15", "url": "https://recherchemedicale.com/article/35577715", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.siny.2022.101334" } }, { "@type": "ScholarlyArticle", "name": "Response categorization and outcomes in extremely premature infants born at 22-26 weeks gestation that received inhaled nitric oxide for hypoxic respiratory failure.", "datePublished": "2022-12-12", "url": "https://recherchemedicale.com/article/36509816", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41372-022-01582-4" } }, { "@type": "ScholarlyArticle", "name": "Fragility and resilience: parental and family perspectives on the impacts of extreme prematurity.", "datePublished": "2023-03-30", "url": "https://recherchemedicale.com/article/36997307", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/archdischild-2022-325011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://recherchemedicale.com/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://recherchemedicale.com/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Solutions pharmaceutiques", "item": "https://recherchemedicale.com/mesh/D019999" }, { "@type": "ListItem", "position": 5, "name": "Solutions d'alimentation parentérale", "item": "https://recherchemedicale.com/mesh/D057947" }, { "@type": "ListItem", "position": 6, "name": "Émulsion lipidique intraveineuse", "item": "https://recherchemedicale.com/mesh/D005217" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Émulsion lipidique intraveineuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Émulsion lipidique intraveineuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Émulsion lipidique intraveineuse", "description": "Comment diagnostiquer une carence lipidique ?\nQuels tests sont utilisés pour évaluer les lipides ?\nQuels signes indiquent un besoin d'émulsion lipidique ?\nComment évaluer l'efficacité d'une émulsion lipidique ?\nQuels symptômes peuvent indiquer une surdose lipidique ?", "url": "https://recherchemedicale.com/mesh/D005217?mesh_terms=Infant,+Extremely+Premature&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Émulsion lipidique intraveineuse", "description": "Quels symptômes d'une carence en acides gras ?\nQuels signes d'une réaction allergique aux lipides ?\nComment reconnaître une surcharge lipidique ?\nQuels symptômes d'une embolie lipidique ?\nQuels signes d'une infection liée à l'administration ?", "url": "https://recherchemedicale.com/mesh/D005217?mesh_terms=Infant,+Extremely+Premature&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Émulsion lipidique intraveineuse", "description": "Comment prévenir les complications des émulsions lipidiques ?\nQuelles précautions lors de l'administration ?\nComment éviter les réactions allergiques ?\nQuelles sont les recommandations pour les patients ?\nComment gérer les risques d'infection ?", "url": "https://recherchemedicale.com/mesh/D005217?mesh_terms=Infant,+Extremely+Premature&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Émulsion lipidique intraveineuse", "description": "Comment administrer une émulsion lipidique ?\nQuelles sont les indications des émulsions lipidiques ?\nComment ajuster la dose d'émulsion lipidique ?\nQuels sont les types d'émulsions lipidiques disponibles ?\nQuels sont les effets secondaires possibles ?", "url": "https://recherchemedicale.com/mesh/D005217?mesh_terms=Infant,+Extremely+Premature&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Émulsion lipidique intraveineuse", "description": "Quelles sont les complications possibles des émulsions lipidiques ?\nComment reconnaître une embolie lipidique ?\nQuels sont les risques d'infection liés aux émulsions ?\nComment gérer une surcharge lipidique ?\nQuels tests pour surveiller les complications ?", "url": "https://recherchemedicale.com/mesh/D005217?mesh_terms=Infant,+Extremely+Premature&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Émulsion lipidique intraveineuse", "description": "Quels sont les facteurs de risque d'une carence lipidique ?\nQui est à risque de complications liées aux lipides ?\nQuels médicaments augmentent le risque d'effets secondaires ?\nComment l'âge influence-t-il les risques ?\nQuels antécédents médicaux sont préoccupants ?", "url": "https://recherchemedicale.com/mesh/D005217?mesh_terms=Infant,+Extremely+Premature&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence lipidique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des analyses sanguines et l'évaluation clinique des symptômes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les lipides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent le dosage des triglycérides et du cholestérol dans le sang." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin d'émulsion lipidique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une malnutrition, une perte de poids significative et des troubles métaboliques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'une émulsion lipidique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par le suivi des niveaux de lipides sanguins et des paramètres nutritionnels." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une surdose lipidique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des nausées, des vomissements et des troubles respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'une carence en acides gras ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la fatigue, la peau sèche et des troubles immunitaires." } }, { "@type": "Question", "name": "Quels signes d'une réaction allergique aux lipides ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, des démangeaisons et des difficultés respiratoires peuvent apparaître." } }, { "@type": "Question", "name": "Comment reconnaître une surcharge lipidique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une surcharge peut se manifester par des troubles hépatiques et des anomalies de coagulation." } }, { "@type": "Question", "name": "Quels symptômes d'une embolie lipidique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs thoraciques, une dyspnée et des signes neurologiques." } }, { "@type": "Question", "name": "Quels signes d'une infection liée à l'administration ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs, des gonflements et de la fièvre peuvent indiquer une infection au site d'injection." } }, { "@type": "Question", "name": "Comment prévenir les complications des émulsions lipidiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une surveillance régulière des niveaux lipidiques et une administration correcte." } }, { "@type": "Question", "name": "Quelles précautions lors de l'administration ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de vérifier la compatibilité des solutions et de surveiller les signes d'infection." } }, { "@type": "Question", "name": "Comment éviter les réactions allergiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un historique médical complet et des tests allergiques peuvent aider à éviter les réactions." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les patients ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les patients doivent être informés des signes d'alerte et de l'importance de la surveillance." } }, { "@type": "Question", "name": "Comment gérer les risques d'infection ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques d'asepsie strictes et une formation du personnel sont essentielles pour prévenir les infections." } }, { "@type": "Question", "name": "Comment administrer une émulsion lipidique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'émulsion est administrée par voie intraveineuse, souvent en perfusion continue." } }, { "@type": "Question", "name": "Quelles sont les indications des émulsions lipidiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont indiquées pour la nutrition parentérale, en cas de malabsorption ou de jeûne prolongé." } }, { "@type": "Question", "name": "Comment ajuster la dose d'émulsion lipidique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La dose est ajustée en fonction des besoins caloriques et des niveaux de lipides sanguins." } }, { "@type": "Question", "name": "Quels sont les types d'émulsions lipidiques disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les types incluent les émulsions à base d'huile de soja, d'huile de coco et d'huile d'olive." } }, { "@type": "Question", "name": "Quels sont les effets secondaires possibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des nausées, des vomissements et des réactions allergiques." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des émulsions lipidiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'embolie lipidique, les infections et les troubles métaboliques." } }, { "@type": "Question", "name": "Comment reconnaître une embolie lipidique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des douleurs thoraciques, une dyspnée et des anomalies neurologiques." } }, { "@type": "Question", "name": "Quels sont les risques d'infection liés aux émulsions ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les infections peuvent survenir au site d'injection, nécessitant une surveillance étroite." } }, { "@type": "Question", "name": "Comment gérer une surcharge lipidique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut l'arrêt de l'administration et le traitement des symptômes associés." } }, { "@type": "Question", "name": "Quels tests pour surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins réguliers pour évaluer les lipides et la fonction hépatique sont recommandés." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'une carence lipidique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une malnutrition, des troubles gastro-intestinaux et des jeûnes prolongés." } }, { "@type": "Question", "name": "Qui est à risque de complications liées aux lipides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les patients immunodéprimés, ceux avec des maladies chroniques et les nouveau-nés sont à risque." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'effets secondaires ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments anticoagulants et immunosuppresseurs peuvent augmenter les risques." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir une tolérance réduite aux lipides, augmentant les risques." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont préoccupants ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de maladies hépatiques ou de troubles métaboliques sont préoccupants." } } ] } ] }

Sources (10000 au total)

Dutch professionals' discussion preferences with the parents of extremely premature infants varied, but the trend was towards shared decision-making.

We explored professionals' views on sharing decision-making with parents before and after an extremely preterm birth and what healthcare professionals considered severe outcomes.... A nationwide, multi-centre online survey was carried out among a wide range of perinatal healthcare professionals in the Netherlands from 4 November 2020 to 10 January 2021. The medical chairs of all ... We received 769 survey responses. Most respondents (53%) preferred to place equal emphasis on two treatment options during shared prenatal decision-making: early intensive care or palliative comfort c... Although Dutch professionals expressed diverse preferences on how to reach decisions about extremely premature infants, we observed a trend towards shared decision-making with parents. These results c...

Response categorization and outcomes in extremely premature infants born at 22-26 weeks gestation that received inhaled nitric oxide for hypoxic respiratory failure.

To evaluate the outcomes of extremely premature infants who received inhaled nitric oxide(iNO) for hypoxic respiratory failure(HRF).... Retrospective analysis of 107 infants born 22-26 weeks gestation who received iNO for HRF at a single institution. Infants were categorized as positive, negative, or no responders based on change in F... 63% of infants had a positive response; they received iNO earlier and were more likely to have acute pulmonary hypertension(PH). Positive response correlated with decreased incidence of death or grade... Extremely premature infants have a positive response rate to iNO comparable to term infants when used for PH in the transitional period. Infants with a negative response to iNO had worse outcomes, nec...

Fragility and resilience: parental and family perspectives on the impacts of extreme prematurity.

Extremely preterm babies have a significant risk of neurodevelopmental impairment (NDI). There has been little investigation regarding the impact of prematurity on families. The objective of this stud... Over 1 year, parents of children born <29 weeks' gestational age (GA) who were between 18 months old and 7 years old and came for their follow-up visit were invited to participate. They were asked to ... Among parents (n=248, 98% participation rate), most (74%) reported that their child's prematurity had both positive and negative impacts on their life or their family's life, while 18% reported only p... Parents report both positive and negative impacts after an extremely preterm birth, independent of disability. These balanced perspectives should be included in neonatal research, clinical care and pr...

Neonatal Sepsis Episodes and Retinopathy of Prematurity in Very Preterm Infants.

Retinopathy of prematurity (ROP) is a major morbidity of preterm infants causing visual impairment, including blindness, for which timely treatment is vital and prevention is key. Increasing evidence ... To investigate the association between neonatal sepsis and ROP in 2 large-scale cohorts of preterm infants born at less than 29 weeks' gestation.... This retrospective cohort study was conducted using data from the German Neonatal Network (GNN) and Norwegian Neonatal Network (NNN). The GNN involves 68 and the NNN includes 21 level III neonatal int... Single or multiple episodes of culture-proven sepsis.... Any ROP and treatment-warranted ROP.... Among 12 794 infants in the GNN (6043 female [47.2%] and 6751 male [52.8%]; mean [SD] gestational age, 26.4 [1.5] weeks) and 1844 infants in the NNN (866 female [47.0%] and 978 male [53.0%]; mean [SD]... This study found that in the large-scale GNN cohort, recurrent culture-proven sepsis was associated with ROP and treatment-warranted ROP in infants born at less than 29 weeks....

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.

Very preterm infants often require respiratory support and are therefore exposed to an increased risk of bronchopulmonary dysplasia (chronic lung disease) and later neurodevelopmental disability. Caff... To determine the effects of higher versus standard doses of caffeine on mortality and major neurodevelopmental disability in preterm infants with (or at risk of) apnea, or peri-extubation.... We searched CENTRAL, MEDLINE, Embase, CINAHL, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), and clinicaltrials.gov in May 2022. The reference lists of re... We included randomized (RCTs), quasi-RCTs and cluster-RCTs, comparing high-dose to standard-dose strategies in preterm infants. High-dose strategies were defined as a high-loading dose (more than 20 m... We used standard methodological procedures expected by Cochrane. We evaluated treatment effects using a fixed-effect model with risk ratio (RR) for categorical data and mean, standard deviation (SD), ... High-dose caffeine strategies in preterm infants may have little or no effect on reducing mortality prior to hospital discharge or side effects. We are very uncertain whether high-dose caffeine strate...

Regional differences of tracheostomy in extremely premature neonates across the United States.

To identify regional differences in tracheostomy rates and mortality in extremely premature neonates.... The 1997-2019 Kids' Inpatient Databases (KID) were queried to identify children who completed 27 weeks gestation (27-wk) or less and 23 weeks gestation (23-wk) or less. Multivariable logistic regressi... There were 2433 27-wk or less infants and 259 23-wk or less who received a tracheostomy. The MW was the only region where higher odds of tracheostomy were seen for 27-wk or less (aOR 1.25 [95%CI 1.12-... This study identified regional differences in tracheostomy rates in extremely premature infants. Extremely premature neonates in the MW had higher odds of receiving a tracheostomy with comparable mort...